MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Beispiel ServiceRequest: Phase 1/2 CLDN6 CAR-T-Zell-Studie


German


Profile: MII PR MTB Studieneinschluss Anfrage version: 2027.0.0-ballot.1

MII EX MTB Empfehlung Priorität: 2.1

MII EX MTB Empfehlung Publikation: http://www.ncbi.nlm.nih.gov/pubmed/37872225

status: Draft

intent: Proposal

category: Clinical trial (procedure)

code: Referral to clinical trial (procedure)

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

supportingInfo: ResearchStudy: identifier = https://www.medizininformatik-initiative.de/fhir/modul-mtb/sid/nct#MII_NS_MTB_NCT#04503278; status = active; primaryPurposeType = treatment; phase = phase-1; condition = Solid tumor configuration; keyword = ; period = 2020-09-16 --> 2040-01